These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35765128)

  • 1. Relatively Poor Long-term Outcomes Following Liver Transplantation for NASH in the United States.
    Jamil OK; Sandikçi B; Faust N; Cotter TG; Paul S; di Sabato D; Fung J; Charlton M
    Transplantation; 2022 Oct; 106(10):2006-2018. PubMed ID: 35765128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study.
    Haldar D; Kern B; Hodson J; Armstrong MJ; Adam R; Berlakovich G; Fritz J; Feurstein B; Popp W; Karam V; Muiesan P; O'Grady J; Jamieson N; Wigmore SJ; Pirenne J; Malek-Hosseini SA; Hidalgo E; Tokat Y; Paul A; Pratschke J; Bartels M; Trunecka P; Settmacher U; Pinzani M; Duvoux C; Newsome PN; Schneeberger S;
    J Hepatol; 2019 Aug; 71(2):313-322. PubMed ID: 31071367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic Steatohepatitis.
    Agbim U; Jiang Y; Kedia SK; Singal AK; Ahmed A; Bhamidimarri KR; Bernstein DE; Harrison SA; Younossi ZM; Satapathy SK
    Liver Transpl; 2019 Jan; 25(1):68-78. PubMed ID: 30091296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Pretransplant Renal Function With Liver Graft and Patient Survival After Liver Transplantation in Patients With Nonalcoholic Steatohepatitis.
    Molnar MZ; Joglekar K; Jiang Y; Cholankeril G; Abdul MKM; Kedia S; Gonzalez HC; Ahmed A; Singal A; Bhamidimarri KR; Aithal GP; Duseja A; Wong VW; Gulnare A; Puri P; Nair S; Eason JD; Satapathy SK;
    Liver Transpl; 2019 Mar; 25(3):399-410. PubMed ID: 30369023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.
    Charlton MR; Burns JM; Pedersen RA; Watt KD; Heimbach JK; Dierkhising RA
    Gastroenterology; 2011 Oct; 141(4):1249-53. PubMed ID: 21726509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor Survival After Retransplantation in NASH Cirrhosis.
    Thuluvath AJ; Chen PH; Thuluvath PJ; Kantsevoy S; Savva Y
    Transplantation; 2019 Jan; 103(1):101-108. PubMed ID: 29470354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic Steatohepatitis is the Most Rapidly Growing Indication for Simultaneous Liver Kidney Transplantation in the United States.
    Singal AK; Hasanin M; Kaif M; Wiesner R; Kuo YF
    Transplantation; 2016 Mar; 100(3):607-12. PubMed ID: 26479282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation.
    Kern B; Feurstein B; Fritz J; Fabritius C; Sucher R; Graziadei I; Bale R; Tilg H; Zoller H; Newsome P; Eschertzhuber S; Margreiter R; Öfner D; Schneeberger S
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):205-210. PubMed ID: 30320609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and risk factors for recurrence of nonalcoholic steatohepatitis following liver transplantation.
    Tokodai K; Karadagi A; Kjaernet F; Romano A; Ericzon BG; Nowak G
    Scand J Gastroenterol; 2019 Feb; 54(2):233-239. PubMed ID: 30999770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.
    Castelló B; Aguilera V; Blázquez MT; Rubín Á; García M; Vinaixa C; Benlloch S; SanJuan F; Montalva E; López R; Berenguer M
    Ann Hepatol; 2019; 18(6):855-861. PubMed ID: 31543468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttransplant Outcome of Lean Compared With Obese Nonalcoholic Steatohepatitis in the United States: The Obesity Paradox.
    Satapathy SK; Jiang Y; Agbim U; Wu C; Bernstein DE; Teperman LW; Kedia SK; Aithal GP; Bhamidimarri KR; Duseja A; Maiwall R; Maliakkal B; Jalal P; Patel K; Puri P; Ravinuthala R; Wong VW; Abdelmalek MF; Ahmed A; Thuluvath PJ; Singal AK;
    Liver Transpl; 2020 Jan; 26(1):68-79. PubMed ID: 31665561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Liver Transplantation Among Older Recipients With Nonalcoholic Steatohepatitis in a Large Multicenter US Cohort: the Re-Evaluating Age Limits in Transplantation Consortium.
    Kwong AJ; Devuni D; Wang C; Boike J; Jo J; VanWagner L; Serper M; Jones L; Sharma R; Verna EC; Shor J; German MN; Hristov A; Lee A; Spengler E; Koteish AA; Sehmbey G; Seetharam A; John N; Patel Y; Kappus MR; Couri T; Paul S; Salgia RJ; Nhu Q; Frenette CT; Lai JC; Goel A;
    Liver Transpl; 2020 Nov; 26(11):1492-1503. PubMed ID: 33047893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation for nonalcoholic steatohepatitis: the new epidemic.
    Agopian VG; Kaldas FM; Hong JC; Whittaker M; Holt C; Rana A; Zarrinpar A; Petrowsky H; Farmer D; Yersiz H; Xia V; Hiatt JR; Busuttil RW
    Ann Surg; 2012 Oct; 256(4):624-33. PubMed ID: 22964732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of Nonalcoholic Steatohepatitis After Liver Transplantation: An Updated Meta-Analysis and Systematic Review.
    Yong JN; Lim WH; Ng CH; Tan DJH; Xiao J; Tay PWL; Lin SY; Syn N; Chew N; Nah B; Dan YY; Huang DQ; Tan EXX; Sanyal AJ; Noureddin M; Siddiqui MS; Muthiah MD
    Clin Gastroenterol Hepatol; 2023 Jan; 21(1):45-54.e6. PubMed ID: 34801743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016.
    Golabi P; Bush H; Stepanova M; Locklear CT; Jacobson IM; Mishra A; Trimble G; Erario M; Venkatesan C; Younossi I; Goodman Z; Younossi ZM
    Medicine (Baltimore); 2018 Aug; 97(31):e11518. PubMed ID: 30075518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic Steatohepatitis is the Most Rapidly Increasing Indication for Liver Transplantation in Young Adults in the United States.
    Doycheva I; Issa D; Watt KD; Lopez R; Rifai G; Alkhouri N
    J Clin Gastroenterol; 2018 Apr; 52(4):339-346. PubMed ID: 28961576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.
    Cholankeril G; Wong RJ; Hu M; Perumpail RB; Yoo ER; Puri P; Younossi ZM; Harrison SA; Ahmed A
    Dig Dis Sci; 2017 Oct; 62(10):2915-2922. PubMed ID: 28744836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation for NASH cirrhosis is not performed at the expense of major post-operative morbidity.
    van den Berg EH; Douwes RM; de Meijer VE; Schreuder TCMA; Blokzijl H
    Dig Liver Dis; 2018 Jan; 50(1):68-75. PubMed ID: 28935188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portrait of Regional Trends in Liver Transplantation for Nonalcoholic Steatohepatitis in the United States.
    Yuan L; Hanlon CL; Terrault N; Alqahtani S; Tamim H; Lai M; Saberi B
    Am J Gastroenterol; 2022 Mar; 117(3):433-444. PubMed ID: 35083985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the outcome of liver transplantation in patients with non-alcoholic steatohepatitis cirrhosis: The NASH LT risk-benefit calculator.
    Karnam RS; Punchhi G; Mitsakakis N; Chen S; Saracino G; Lilly L; Asrani SK; Bhat M
    Clin Transplant; 2023 Apr; 37(4):e14930. PubMed ID: 36762716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.